Pages

Tuesday, 14 April 2020

South Dakota Institutes Statewide Hydroxychloroquine Trial To Test Effectiveness Against COVID-19

South Dakota Gov. Kristi Noem announced on Monday a statewide clinical trial of hydroxychloroquine to test its efficacy for treatment of COVID-19 patients.
“From day one, I’ve said we’re going to let the science, facts, and data drive our decisions in South Dakota,” Noem tweeted.
“Throughout last week, I communicated with White House officials to let them know that SD’s medical community was ready to step up and lead the way on research efforts,” the GOP governor added.
From day one, I’ve said we’re going to let the science, facts, and data drive our decisions in South Dakota.

Throughout last week, I communicated with White House officials to let them know that SD’s medical community was ready to step up and lead the way on research efforts.
I made direct requests to @POTUS and @VP Pence to supply us with enough hydroxychloroquine so that it could be made available for every hospitalized person in the state, as well as for those healthcare workers on the frontlines and those in the most vulnerable populations.
391 people are talking about this

Noem said she made direct requests to President Donald Trump and Vice President Mike Pence to provide South Dakota with enough hydroxychloroquine to make it available for every hospitalized person.
She also wants to make the drug available to health care workers on the front lines and those in the most vulnerable populations to test its effectiveness as a prophylactic.
Noem added in a follow-up tweet that South Dakota had received the doses needed and that Sanford Health, with the assistance of medical teams at Avera and Monument Health, will conduct the trial.
We’ve received the initial doses we need.

Thanks to the leadership, of @SanfordHealth with assistance from @AveraHealth & @_monumenthealth, we’re now the first state to do a full clinical trial to test whether hydroxychloroquine can treat and perhaps prevent
256 people are talking about this
“Our goal is to meaningfully advance the science around COVID-19 so physicians can be better prepared to respond to and treat this novel virus in the future, especially for our populations most at-risk,” Dr. Allison Suttle, Sanford Health’s chief medical officer, said.
“Taking care of patients with an illness for which there are no treatments is very difficult for a physician and concerning for patients and families. By doing clinical trials during this pandemic, we are trying to find treatments and, thereby, hope,” she added.
Ultimately, up to 100,000 patients could be treated with hydroxychloroquine as part of the trial.
Noem told Fox News that she is “a lot better being on offense than … on defense,” so that is why she pushed for South Dakota to launch this first of its kind statewide and state backed trial.
Participation in the study will be voluntary, she said.
The use of the 75-year-old anti-malaria drug has become a political football after Trump advocated for it being employed to treat COVID-19 patients beginning last month.
“And I hope they use the hydroxychloroquine, and they can also do it with Z-Pak, subject to your doctor’s approval, and all of that,” Trump said, during a news briefing earlier this month. “But I hope they use it because I’ll tell you what: What do you have to lose?”
The president added that the federal government had currently secured 29 million doses, but more was on the way.
On March 28, the Food and Drug Administration granted an emergency authorization for hydroxychloroquine use for coronavirus patients.
“Based on the totality of scientific evidence available to FDA, it is reasonable to believe that chloroquine phosphate and hydroxychloroquine sulfate may be effective in treating COVID-19,” FDA Chief Scientist Denise Hinton wrote in the approval letter.
“When used under the conditions described in this authorization, the known and potential benefits of chloroquine phosphate and hydroxychloroquine sulfate when used to treat COVID-19 outweigh the known and potential risks of such products.”
Last week, when asked about use of the drug in New York, Gov. Andrew Cuomo said that while no extensive scientific study had been done, “anecdotally, it’s been positive.”
Dr. Stephen Smith, founder of the Smith Center for Infectious Diseases and Urban Health in East Orange, New Jersey, said the remarkable results he is seeing in his COVID-19 patients using a combination of the anti-malaria drug hydroxychloroquine and the antibiotic azithromycin marks the “beginning of the end” of the coronavirus pandemic.
Similarly, Dr. Anthony Cardillo of Los Angeles told KABC-TV last week that he has been prescribing hydroxychloroquine in combination with zinc for the most severely ill COVID-19 patients with astounding results.

“Every patient I’ve prescribed it to has been very, very ill and within 8 to 12 hours, they were basically symptom-free,” Cardillo said. “So clinically I am seeing a resolution.”

No comments:

Post a comment